CDK5RAP3 Antibodies

Santa Cruz Biotechnology delivers a wide array of CDK5RAP3 monoclonal antibodies for research focused on understanding CDK5RAP3's role in cellular processes. CDK5RAP3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CDK5RAP3, or Cyclin-dependent kinase 5 regulatory subunit-associated protein 3, plays a crucial role in regulating neuronal development and synaptic function. CDK5RAP3 is involved in the modulation of CDK5 activity, which is essential for proper neuronal signaling and has implications in neurodegenerative diseases. Understanding CDK5RAP3 function is vital for elucidating the mechanisms underlying various neurological disorders. CDK5RAP3 research has revealed significant insights into neuronal development pathways and potential therapeutic targets. Ongoing studies continue to uncover new functions and regulatory mechanisms of CDK5RAP3 in cellular signaling networks. Research utilizing CDK5RAP3 monoclonal antibodies has enhanced our understanding of neurodegenerative disease progression. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific discoveries in neuroscience and cellular biology.